Comparison of diltiazem and atenolol in young, physically active men with essential hypertension.

The antihypertensive efficacy and effect on maximal exercise performance of diltiazem was evaluated and compared with atenolol in patients specifically selected on the basis of their being young and physically active. Diltiazem (sustained-release preparation, 90 mg twice daily) was administered to 14 patients (aged 33 +/- 2 years) and atenolol (50 mg once daily) to 13 patients (aged 30 +/- 2 years) with essential hypertension in a 16-week randomized, double-blind, parallel study. The 2 drugs had comparable antihypertensive effects at rest, with mean decreases of 18 and 17 mm Hg (p less than 0.001) for supine and standing diastolic blood pressure (BP), respectively, during diltiazem treatment, and mean decreases of 21 and 18 mm Hg (p less than 0.001) during atenolol treatment. During maximal graded exercise testing, systolic BP, diastolic BP, heart rate and heart rate-BP product were significantly reduced by both drugs. However, the reductions in systolic BP, heart rate and heart rate-BP product during exercise were considerably greater (p less than 0.001) with atenolol than with diltiazem. Maximal exercise performance was essentially unchanged with diltiazem and slightly (3%, p less than 0.05) reduced with atenolol. Thus, diltiazem is effective and well-tolerated single therapy for young patients with mild to moderate essential hypertension who lead a physically active life style and compares favorably with atenolol.

The early signs of right bundle branch block.

Complete right bundle branch block manifests with a rSR' configuration in right orientated leads and a duration of 0.12 sec or longer. Incomplete right bundle branch block is perceived as this classic rSr' configuration and a duration of less than 0.12 sec. This presentation reflects the early development of right bundle branch block which first manifests with a hitherto undescribed sign, namely: a diminution of the S wave amplitude in lead V2. Further progression of the right bundle branch block leads to slurring or notching of the upstroke of the S wave in lead V2 followed by the development of a r' deflection. With further progression, the r' deflection becomes increasingly taller until the advent of complete right bundle branch block which is characterized by a widening of a very tall R' deflection with an apical notch or plateau.

Reciprocating tachycardia with only odd-numbered beats in the Wolff-Parkinson-White syndrome.

A case of Wolff-Parkinson-White syndrome with reciprocating tachycardia from retrograde Kent's bundle conduction is described. The paroxysms of reciprocating tachycardia manifested with the unusual, and hitherto unreported, feature of only odd-numbered beats. The phenomenon is explained on the basis of alternate anterograde conduction through two A-V nodal pathways.

Oral propafenone in the suppression of chronic stable ventricular arrhythmias.

The efficacy of propafenone hydrochloride, a new antiarrhythmic agent, was evaluated in the treatment of chronic stable ventricular arrhythmias. Twenty-five patients who had suffered a myocardial infarction three months or longer before the trial were studied. All exhibited a minimum mean frequency of 30 ventricular ectopic beats per hour over at least two 24-hour Holter monitoring periods with the last recorded tape serving as a control. The mean decrease in ventricular ectopic activity with propafenone was 65.62 percent (p = less than 0.001). Side effects were infrequent, minimal, and of no clinical consequence. Oral propafenone was found to be an effective drug for reducing the level of chronic ventricular ectopy, as reflected by a short-term trial.

Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators.

A double-blind, placebo-controlled, multicenter trial was undertaken to assess the antihypertensive efficacy and tolerability of a controlled-release (Coat-Core [CC] tablet) formulation of the second-generation dihydropyridine calcium channel antagonist, nisoldipine. Of the 208 patients with mild-to-moderate essential hypertension, two were excluded from the main efficacy analysis, and the rest randomized into one of four treatment groups, to receive either placebo, or nisoldipine CC at doses of 10, 20, or 30 mg once daily for 6 weeks, following a 4-week placebo run-in period. Blood pressure measurements (supine, standing, diastolic, and systolic) were taken at trough plasma levels, 24 h after previous dosing at 2-week intervals throughout the study. Adverse events and laboratory parameters (plasma lipid and glucose levels, and thyroid function) were monitored. All three doses of nisoldipine CC lowered blood pressure, as compared with placebo, 24 h after dosing. At endpoint (after 6 weeks) mean changes in supine blood pressure from baseline were (systolic/diastolic) 0.9/-2.3, -8.0/-5.5, -16.9/-9.0, and -15.0/-10.3 mm Hg for the groups assigned to placebo and nisoldipine CC 10, 20, and 30 mg, respectively. The response rates were 35%, 47%, and 63% for nisoldipine CC 10, 20, and 30 mg, respectively. Twenty-four-hour ambulatory blood pressure monitoring showed that nisoldipine CC effectively controlled blood pressure throughout the dosing interval. No change in heart rate was seen for all three doses of nisoldipine CC over the 24-h dosing interval. Nisoldipine CC was at least as effective in black patients as in whites. Generally adverse events were not increased, except for peripheral edema, with rates of 7% in placebo, and 6%, 9%, and 19%, respectively, in those receiving nisoldipine CC 10, 20, or 30 mg daily. There were no clinically significant changes in blood lipids, blood glucose, or thyroid function. In conclusion, once-daily nisoldipine CC at doses of 10 to 30 mg was an effective and well tolerated antihypertensive agent, providing 24-h control of blood pressure without any increase in heart rate.

Antioxidant vitamins and coronary artery disease risk in South African males.

Decreased antioxidant-vitamin nutritional status may increase lipid peroxidation and susceptibility of low-density lipoprotein (LDL) to oxidative modification. The aim of this study was to evaluate the vitamin nutritional status of coronary artery disease (CAD) patients and to assess the risk of CAD related to each individual antioxidant vitamin. The study was performed as a case-control study with 41 patients with angiographically demonstrated CAD and 41 apparently healthy age- and smoking status-matched controls. Plasma vitamin E, C and A concentrations were significantly decreased in CAD patients compared with controls (p < 0.001) after correcting for significant covariates. Per quartile decrease in vitamin A and E concentrations was associated with increased risk of CAD, even after adjusting for CAD risk factors, while per quartile decrease in vitamin C concentrations was not associated with significant CAD risk after adjusting for CAD risk factors. Decreased vitamin A and E concentrations are independently associated with increased risk of CAD independent from other CAD risk factors in white male South Africans and dietary intervention strategies are advocated.

Effect of beta-blockade on exercise core temperature in coronary artery disease patients.

The effect of pharmacologic blockade of beta-adrenoceptors on the relationship between rectal (Tre) and pulmonary artery (Tpa) temperatures was studied in six coronary artery disease patients during 30 min of exercise. Exercise was performed at a set work rate (120 W) on a cycle ergometer before and 2 h after the ingestion of 80 mg propranolol. The heart rate on completion of exercise was reduced (P less than 0.001) from 140 +/- 5 to 108 +/- 3 beats.min-1 by propranolol demonstrating a considerable degree of beta-adrenoceptor blockade. At rest, neither Tre nor Tpa were modified by propranolol. Likewise, propranolol failed to modify the Tre response to exercise. However, propranolol induced an alteration of the normal relationship between Tre and Tpa during exercise. In particular, although Tre was essentially unchanged, propranolol accentuated both the initial fall (by 0.28 degrees C, P less than 0.001) and the subsequent rise (by 0.46 degrees C, P less than 0.01) in Tpa during exercise. The present data therefore demonstrate a considerable limitation to the use of Tre when assessing thermal homeostasis during acute beta-adrenoceptor blockade. Furthermore, although research with more chronic therapy is warranted, our study suggests an accentuated risk of hyperthermia and, by implication, its adverse physiologic consequences during prolonged exercise performed by coronary artery disease patients treated with propranolol.

Effect of dual beta-blockade and calcium antagonism on endurance performance.

The effect of oral clinically used doses of propranolol, atenolol, nifedipine, propranolol + nifedipine, and atenolol + nifedipine on endurance performance and ventilatory responses to graded treadmill testing was studied in 12 healthy physically active men. Maximal exercise duration was reduced by propranolol (8.5%, P less than 0.001) and its combination with nifedipine (11.1%, P less than 0.001), and to a lesser degree by atenolol (3.2%, 0.05 less than P less than 0.1), nifedipine (2.1%, P less than 0.05), and atenolol + nifedipine (3.9%, P less than 0.01). Exercise duration and heart rate (HR) and ventilatory responses to maximal exercise were equivalent with a beta-blocker and its combination with nifedipine. At submaximal exercise, beta-blockade reduced the HR and oxygen uptake, nifedipine accentuated the HR but did not alter ventilation, and all drugs modified the relative oxygen uptake corresponding to 85% of the maximal HR. Physiologic responses to submaximal exercise during combination therapy were similar to those during beta-blockade alone. This study concludes that, in physically active men, nifedipine induces a small impairment of maximal performance, but does not accentuate the reduction in effort tolerance resulting from beta-blockade. Furthermore, HR and ventilatory responses to exercise during combined beta-blockade and calcium antagonism can be predicted from those during beta-blockade alone.

Grand mal epilepsy as recorded during dynamic electrocardiography.

A patient with diagnosed epilepsy was followed at a post-myocardial infarction clinic with routine ambulatory electrocardiographic monitoring. On one particular occasion while being monitored, he manifested an epileptic seizure. The features and duration of the seizure were reflected in the electrocardiographic recording. Cardiac arrhythmias may result in epileptiform seizures which may be mediated either through vagomedullary reticular pathways or through cerebral hypoxia as a result of the hemodynamic disturbance. The apparent epilepsy may vary from confused behavior to a generalized seizure and may thus mimic true cryptogenic epilepsy. The following case concerns a post-myocardial infarction patient with diagnosed epilepsy who sustained a seizure which was documented by an ambulatory electrocardiographic recorder.

Apical hypertrophic nonobstructive cardiomyopathy in a pilot.

Apical hypertrophic cardiomyopathy is a form of nonobstructive hypertrophic cardiomyopathy characterized by disproportionate hypertrophy of the left ventricular apical region. With increasing reports of apical hypertrophic cardiomyopathy appearing in the literature, this condition is certain to be diagnosed amongst airmen. The question of flying status in these pilots may create a problem for the flight surgeon. We present a pilot with clinical and morphological features typical of apical hypertrophic cardiomyopathy who has remained asymptomatic over a 15-year follow-up period. There appears to be a spectrum of severity in apical hypertrophic cardiomyopathy ranging from mild to severe. Those having the mild form of the disease may be considered for restricted licensing subject to having a normal exercise test and no significant arrhythmias on 24-h ambulatory electro-cardiogram. If licensed, review by a cardiologist should be required every 6 months.

The Wolff-Parkinson-White pattern in health aircrew.

The Wolff-Parkinson-White syndrome has been studied in a group of healthy aviation personnel over the past 15 years. The incidence of this electrocardiographic pattern has been determined in 22,500 healthy individuals and found to be 0.25%. The prevalence of documented tachyarrhythmias in this group of individuals was found to be only 1.8% while in a group of referred patients the prevalence was 20%. The limitations of the widely accepted classification into Type A and Type B patterns was borne out by our inability to categorize 45% of subjects with the WPW pattern. Q waves as QS or QR complexes in the inferior limb leads were found in 16.7% of subjects, but in all there was Q wave-T wave vector discordance. The limited value of stress testing in these individuals was reflected by 30% of our patients who demonstrated false positive signs of ischaemic heart disease. A discussion of the incidence, classification, differential diagnosis, mechanism of tachyarrhythmias, associated cardiovascular anomalies, and treatment follows.

Beta adrenergic blocking agents to control hypertension in aviation personnel.

Beta adrenergic receptor blocking agents were used in the treatment of 15 hypertensive aircrew who had failed to respond to thiazide diuretics. Atenolol (Tenormin) resulted in adequate control of blood pressure in all subjects. Side effects were minimal and insignificant. It is recommended that a cardio-selective, water-soluble beta blocker, such as atenolol, be made available to selected hypertensive aircrew.

Post-exercise time-course analysis of ST segment and T wave changes: an important contribution to the role of stress electrocardiography in aircrew.

Flight surgeons recognize that ongoing vigilance is necessary to detect coronary artery disease (CAD) in aircrew. Regular physical examinations with only a resting electrocardiogram, albeit having a very low predictive value for detection of CAD in asymptomatic subjects, are now widely practised. Routine stress electrocardiography has been criticized for yielding too many so-called "false positive" results because ST/T changes that develop during and after exercise are prevalent. Recent studies in our institution indicate, however, that the time-course behavior patterns of these ST/T configurational "abnormalities" after exercise are different from those reflecting myocardial ischemia due to epicardial CAD. Time-course analysis increases the predictive value of exercise testing and has dramatically decreased the number of asymptomatic aircrew being subjected to coronary arteriography in our institution. Routine exercise electrocardiography provides a reliable, cost-effective means of detecting aircrew with CAD and a baseline for comparison at subsequent examination, and we strongly recommend that it be universally reinstated.

The aeromedical implications of atrial fibrillation.

A retrospective study was undertaken to determine the incidence of spontaneous atrial fibrillation (AF) in a group of asymptomatic pilots. The electrocardiograms of 13,037 aircrew members accumulated between 1964 and 1986 were reviewed and those coded for AF were extracted. In each case an attempt was made to investigate factors relating to the onset, course, and prognosis of the AF. Eight subjects (mean age 50.1 years) were found to have AF. Of this group, two had a single isolated episode of AF for which a specific precipitating factor was implicated, three had recurrent paroxysmal AF of which one progressed to chronic persistent AF, and three had chronic persistent AF from the outset. The mean follow-up period for the eight subjects was 13.6 years. The two pilots who had isolated attacks of AF have thus far had no subsequent episodes of AF. Five of the remaining six have been completely well, while one required treatment for an embolus to his left leg. Concerning the aeromedical implications, we believe that pilots demonstrating single isolated episodes of AF in the presence of a normal heart, and in whom recovery is complete, should be allowed to return to full aviation duties on a waiver clause. Patients with chronic AF, lone AF, or paroxysmal AF should be excluded from all flying duties.

Postexercise blood pressure as a predictor of hypertension.

A study on 721 healthy male aircrew assessed whether the blood pressure response to exercise could be used to predict the development of hypertension. A positive blood pressure response to exercise, recorded 30 s after the completion of exercise, was defined as a systolic blood pressure of 200 torr or more (systolic test) or a raised diastolic blood pressure (diastolic test). While 236 (32.7%) became hypertensive with a blood pressure greater than 149/90 torr, 17% of these had shown a positive systolic response and 17% a positive diastolic response. The other 485 individuals (67.3%) remained normotensive throughout the mean follow-up period of 68 months (range 12-170 months). Of this group, 88% never manifested a positive systolic or diastolic response to exercise. Although 5% of the normotensive subjects manifested a positive systolic response to exercise, and 12% manifested a positive diastolic response to exercise, a longer period of follow-up may reduce this figure. It is concluded that exercise related blood pressure is a useful test in predicting the development of essential hypertension.